103 related articles for article (PubMed ID: 7521978)
1. Comparison of different assays for the quantitation of FK 506 levels in blood or plasma.
Winkler M; Christians U; Stoll K; Baumann J; Pichlmayr R
Ther Drug Monit; 1994 Jun; 16(3):281-6. PubMed ID: 7521978
[TBL] [Abstract][Full Text] [Related]
2. Multicenter comparison of tacrolimus (FK 506) whole blood concentrations as measured by the Abbott IMX analyzer and enzyme immunoassay with methylene chloride extraction.
D'Ambrosio R; Girzaitis N; Jusko WJ
Ther Drug Monit; 1994 Jun; 16(3):287-92. PubMed ID: 7521979
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation.
Winkler M; Christians U; Baumann J; Gonschior AK; Wonigeit K; Pichlmayr R
Ther Drug Monit; 1996 Dec; 18(6):640-6. PubMed ID: 8946659
[TBL] [Abstract][Full Text] [Related]
4. Pitfalls in monitoring tacrolimus (FK 506).
Braun F; Schütz E; Christians U; Lorf T; Schiffmann JH; Armstrong VW; Schröter W; Sewing KF; Oellerich M; Ringe B
Ther Drug Monit; 1997 Dec; 19(6):628-31. PubMed ID: 9421102
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
Marubashi S; Nagano H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Monden M; Doki Y; Mori M
J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
[TBL] [Abstract][Full Text] [Related]
6. Study of the correlation between MEIA and ELISA methods for FK 506 determination in liver transplant recipients.
Rudant E; Bezie Y; Bonhomme-Faivre L; Manuel N; Rucay P; Fredj G; Bismuth H
J Clin Pharm Ther; 1997 Apr; 22(2):135-40. PubMed ID: 9373812
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus analysis: a comparison of different methods and matrices.
Warty V; Zuckerman S; Venkataramanan R; Lever J; Chao J; Mckaveney T; Fung J; Starzl T
Ther Drug Monit; 1995 Apr; 17(2):159-67. PubMed ID: 7542809
[TBL] [Abstract][Full Text] [Related]
8. Monitoring FK 506 concentrations in plasma and whole blood.
Jusko WJ; D'Ambrosio R
Transplant Proc; 1991 Dec; 23(6):2732-5. PubMed ID: 1721260
[TBL] [Abstract][Full Text] [Related]
9. Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression.
Winkler M; Ringe B; Baumann J; Loss M; Wonigeit K; Pichlmayr R
Clin Chem; 1994 Dec; 40(12):2247-53. PubMed ID: 7527306
[TBL] [Abstract][Full Text] [Related]
10. Analysis of tacrolimus (FK 506) in relation to therapeutic drug monitoring.
Jusko WJ
Ther Drug Monit; 1995 Dec; 17(6):596-601. PubMed ID: 8588227
[TBL] [Abstract][Full Text] [Related]
11. HPLC assay for FK 506 and two metabolites in isolated rat hepatocytes and rat liver microsomes.
Perotti BY; Prueksaritanont T; Benet LZ
Pharm Res; 1994 Jun; 11(6):844-7. PubMed ID: 7524055
[TBL] [Abstract][Full Text] [Related]
12. FK506 measurement: comparison of different analytical methods.
Warty V; Zuckerman S; Venkataramanan R; Lever J; Fung J; Starzl T
Ther Drug Monit; 1993 Jun; 15(3):204-8. PubMed ID: 7687389
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus (FK 506): a whole blood assay as measured on the Abbott IMx analyzer.
McKenna BA; Pabico RC; Bronsther OL; Morris MC; Orloff MS; Erturk E
Transplant Proc; 1996 Apr; 28(2):988-90. PubMed ID: 8623491
[No Abstract] [Full Text] [Related]
14. HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients.
Firdaous I; Hassoun A; Otte JB; Reding R; Squifflet JP; Besse T; Wallemacq PE
Clin Chem; 1995 Sep; 41(9):1292-6. PubMed ID: 7544705
[TBL] [Abstract][Full Text] [Related]
15. Radioreceptor assay for quantifying FK-506 immunosuppressant in whole blood.
Murthy JN; Chen Y; Warty VS; Venkataramanan R; Donnelly JG; Zeevi A; Soldin SJ
Clin Chem; 1992 Jul; 38(7):1307-10. PubMed ID: 1377995
[TBL] [Abstract][Full Text] [Related]
16. Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood.
MacFarlane GD; Scheller DG; Ersfeld DL; Shaw LM; Venkatarmanan R; Sarkozi L; Mullins R; Fox BR
Clin Chem; 1999 Sep; 45(9):1449-58. PubMed ID: 10471647
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus metabolite cross-reactivity in different tacrolimus assays.
Murthy JN; Davis DL; Yatscoff RW; Soldin SJ
Clin Biochem; 1998 Nov; 31(8):613-7. PubMed ID: 9876892
[TBL] [Abstract][Full Text] [Related]
18. The use of plasma levels for FK 506 dosing in liver-grafted patients.
Winkler M; Ringe B; Rodeck B; Melter M; Stoll K; Baumann J; Wonigeit K; Pichlmayr R
Transpl Int; 1994 Aug; 7(5):329-33. PubMed ID: 7527638
[TBL] [Abstract][Full Text] [Related]
19. In vitro assessment of FK 506 immunosuppressive activity in transplant patients.
Zeevi A; Venkataramanan R; Warty V; Eiras G; Woan M; Abu-Elmagd K; Alessiani M; Jain A; Demetris AJ; Zerbe T
Transplant Proc; 1991 Dec; 23(6):2897-9. PubMed ID: 1721307
[No Abstract] [Full Text] [Related]
20. In vitro immunosuppressive activity, isolation from pig liver microsomes and identification by electrospray ms-ms of a new FK-506 C19-C20 epoxide metabolite.
Lhoëst G; Dieden R; Verbeeck RK; Maton N; Ingendoh A; Latinne D
J Pharmacol Exp Ther; 1998 Mar; 284(3):1074-81. PubMed ID: 9495869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
